Sudoriferous (Sweat) Gland Disorders – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Sudoriferous (Sweat) Gland Disorders – Drugs In Development, 2024 report and make more profitable business decisions.
Sweat glands, also known as sudoriferous or sudoriparous glands, are small tubular structures of the skin that produce sweat. Sweat glands are a type of exocrine gland, which are glands that produce and secrete substances onto an epithelial surface by way of a duct. It is a skin disease caused by the blockage or inflammation of eccrine sweat glands
The Sudoriferous (Sweat) Gland Disorders drugs in development market research report provide comprehensive information on the therapeutics under development for Sudoriferous (Sweat) Gland Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Sudoriferous (Sweat) Gland Disorders and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Sudoriferous (Sweat) Gland Disorders | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 14 molecules, with 14 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Sudoriferous (Sweat) Gland Disorders therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Sudoriferous (Sweat) Gland Disorders pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Sudoriferous (Sweat) Gland Disorders treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
AbbVie IncAquavit Pharmaceuticals Inc
Atacama Therapeutics Inc
Botanix Pharmaceuticals Ltd
DelNova Inc
Dermata Therapeutics Inc
Dr. August Wolff GmbH & Co KG Arzneimittel
Kaken Pharmaceutical Co Ltd
Maruho Co Ltd
Sinovant Sciences HK Ltd
Staidson BioPharma Inc
Viatris Inc
Vivreon Biosciences LLC
Xero Pharmaceuticals
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Sudoriferous (Sweat) Gland Disorders reports